CHUGAI PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:CHGCF) on Focus After Report of More Shorts

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCF) Logo

The stock of CHUGAI PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:CHGCF) registered an increase of 45.63% in short interest. CHGCF’s total short interest was 299,700 shares in January as published by FINRA. Its up 45.63% from 205,800 shares, reported previously. With 100 shares average volume, it will take short sellers 2997 days to cover their CHGCF’s short positions.

It closed at $59.5 lastly. It is up 0.00% since January 12, 2018 and is . It has by 0.00% the S&P500.

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, marketing, and distribution of prescription medicines in Japan, Switzerland, and internationally. The company has market cap of $33.38 billion. The company's products for oncology include Avastin, Herceptin, Rituxan, Xeloda, Tarceva, Perjeta, Alecensa, Neutrogin, Kadcyla, Zelboraf, Aloxi, and Akynzeo; bone and joint diseases/autoimmune diseases comprise Actemra, Edirol, Suvenyl, Bonviva, and Alfarol; renal diseases consist of Mircera, Oxarol, and Epogin; and transplant, immunology, infectious, and other diseases comprise Tamiflu, CellCept, Copegus, Pegasys, and Sigmart. It has a 41.81 P/E ratio. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases.

More important recent Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCF) news were published by: Seekingalpha.com which released: “Chugai’s HEMLIBRA approved in Taiwan for the treatment of hemophilia A with factor VIII inhibitors – Seeking Alpha” on December 04, 2018, also Seekingalpha.com published article titled: “Chugai’s satralizumab shows positive effect in late-stage study in inflammatory CNS disorder – Seeking Alpha”, Seekingalpha.com published: “Chugai Pharmaceutical (CHGCF) Updates On Projects under Development (R&D Call) – Slideshow – Seeking Alpha” on June 29, 2017. More interesting news about Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCF) was released by: Seekingalpha.com and their article: “Chugai Pharmaceutical Co., Ltd. ADR 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: July 27, 2018.

(adsbygoogle = window.adsbygoogle || []).push({});

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.